Literature DB >> 10488212

Antibiotic susceptibilities of group C and group G streptococci isolated from patients with invasive infections: evidence of vancomycin tolerance among group G serotypes.

T Zaoutis1, B Schneider, L Steele Moore, J D Klein.   

Abstract

A retrospective review of medical records for 32 patients with invasive group C streptococcus (GCS) or group G streptococcus (GGS) infections was performed. MICs and minimum bactericidal concentrations (MBCs) of penicillin, erythromycin, and vancomycin for all isolates were obtained. Tolerance of vancomycin, defined as an MBC 32 or more times higher than the MIC, was exhibited by 18 GGS isolates (54%). The identification of tolerance in clinical isolates of GGS and GCS may have clinical implications in treating these seriously ill patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488212      PMCID: PMC85574          DOI: 10.1128/JCM.37.10.3380-3383.1999

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

Review 1.  Streptococcus zooepidemicus septic arthritis: case report and review of group C streptococcal arthritis.

Authors:  J Collazos; M J Echevarria; R Ayarza; J de Miguel
Journal:  Clin Infect Dis       Date:  1992-10       Impact factor: 9.079

2.  Group-C beta-hemolytic streptococcal bacteremia.

Authors:  J Berenguer; I Sampedro; E Cercenado; J Baraia; M Rodríguez-Créixems; E Bouza
Journal:  Diagn Microbiol Infect Dis       Date:  1992-02       Impact factor: 2.803

Review 3.  Do the beta-hemolytic non-group A streptococci cause pharyngitis?

Authors:  N Cimolai; R W Elford; L Bryan; C Anand; P Berger
Journal:  Rev Infect Dis       Date:  1988 May-Jun

4.  Group C streptococcal infections.

Authors:  M R Kuskie
Journal:  Pediatr Infect Dis J       Date:  1987-09       Impact factor: 2.129

5.  In vitro bactericidal synergy of gentamicin combined with penicillin G, vancomycin, or cefotaxime against group G streptococci.

Authors:  K Lam; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

6.  Group G streptococcal septicaemia: clinical observations and laboratory studies.

Authors:  R G Finch; A Aveline
Journal:  J Infect       Date:  1984-09       Impact factor: 6.072

7.  Group C streptococcal endocarditis: case report and review of the literature.

Authors:  D S Stein; A P Panwalker
Journal:  Infection       Date:  1985 Nov-Dec       Impact factor: 3.553

8.  Group C streptococcal bacteremia: analysis of 88 cases.

Authors:  S F Bradley; J J Gordon; D D Baumgartner; W A Marasco; C A Kauffman
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

Review 9.  Infections due to Lancefield group C streptococci.

Authors:  R A Salata; P I Lerner; D M Shlaes; K V Gopalakrishna; E Wolinsky
Journal:  Medicine (Baltimore)       Date:  1989-07       Impact factor: 1.889

10.  Clinical and microbiological evidence for endemic pharyngitis among adults due to group C streptococci.

Authors:  F A Meier; R M Centor; L Graham; H P Dalton
Journal:  Arch Intern Med       Date:  1990-04
View more
  12 in total

1.  Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States.

Authors:  Douglas J Biedenbach; James E Ross; Thomas R Fritsche; Helio S Sader; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2007-01-10       Impact factor: 5.948

2.  In vitro activities of linezolid, meropenem, and quinupristin-dalfopristin against group C and G streptococci, including vancomycin-tolerant isolates.

Authors:  T Zaoutis; L S Moore; K Furness; J D Klein
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

3.  Group G streptococcal sepsis, septic arthritis and myositis in a patient with severe oral ulcerations.

Authors:  Wu Deng; Laurie Farricielli
Journal:  BMJ Case Rep       Date:  2014-01-27

4.  Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome.

Authors:  Shinnosuke Hashikawa; Yoshitsugu Iinuma; Manabu Furushita; Teruko Ohkura; Toshi Nada; Keizo Torii; Tadao Hasegawa; Michio Ohta
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

5.  Necrotizing fasciitis in a pediatric patient caused by lancefield group g streptococcus: case report and brief review of the literature.

Authors:  John Rausch; Marc Foca
Journal:  Case Rep Med       Date:  2011-12-27

6.  Prevalence of β-hemolytic groups C and F streptococci in patients with acute pharyngitis.

Authors:  Alaa H Al-Charrakh; Jawad K T Al-Khafaji; Rana H S Al-Rubaye
Journal:  N Am J Med Sci       Date:  2011-03

7.  Macrolide resistance in Streptococcus species.

Authors:  A Ilakkiya; Shabana Parveen; C Naveen Kumar; S Swathi
Journal:  J Pharm Bioallied Sci       Date:  2015-04

8.  Peritonsilar abscess requiring intensive care unit admission caused by group C and G Streptococcus: a case report.

Authors:  Nidhi Gupta; Justin Lovvorn; Robert M Centor
Journal:  Cases J       Date:  2009-09-11

9.  Macrolide resistance trends in beta-hemolytic streptococci in a tertiary Korean hospital.

Authors:  Young Uh; Gyu Yel Hwang; In Ho Jang; Hyun Mi Cho; Song Mi Noh; Hyo Youl Kim; Ohgun Kwon; Kap Jun Yoon
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

10.  Group G Streptococcus Infective Endocarditis in Association With Colon Cancer.

Authors:  Ashraf Abugroun; Ramy Zughul; Mina Tawadrous; Margiori Rodriguez
Journal:  Cardiol Res       Date:  2018-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.